University of Oxford, United Kingdom
Disclosure information not submitted.
Ursodeoxycholic acid and severe COVID-19 outcomes in people with liver disease: a cohort study using the OpenSAFELY platform
Tuesday, August 27, 20241:30 PM – 1:45 PM CEST
